1. Navipour E, Neamatshahi M, Barabadi Z, Neamatshahi M, Keykhosravi A. Epidemiology and risk factors of alzheimer's disease in Iran: A systematic review. Iran J Public Health. 2019; 48(12):2133-39. [Full text in Persian] [DOI:10.18502/ijph.v48i12.3544]

2. Mirzaei-Fini F, Dowlati MA, Dehghani Ashkezari M. Investigating the association of val/metpolymorphism of the BDNF gene with the incidence of disease in patients with alzheimer and comparison with healthy elderly people in Iran. Feyz J Kashan Uni Med Sci. 2018; 22:617-23. [Full text in Persian]

3. Bellenguez C, Küçükali   F, Jansen I, Kleineidam L, Moreno-Grau S, Ami N, et al. New insights into the genetic etiology of Alzheimer's disease and related dementias. Nat Genet. 2022; 54:412-36. [DOI:10.1038/s41588-022-01024-z] [PMID] []

4. Armstrong RA. Risk factors for Alzheimer's disease. Folia Neuropathol. 2019; 57(2):87-105. [DOI:10.5114/fn.2019.85929] [PMID]

5. Sims R, Hill M, Williams J. The multiplex model of the genetics of alzheimer's disease. Nat Neurosci. 2020; 23(3):311-322. [DOI:10.1038/s41593-020-0599-5] [PMID]

6. Trepso WL. Risk Factors for Alzheimer's disease. Sci Insigt. 2020; 32(2):125-32. [DOI:10.15354/si.20.re036]

7. Ferreira Silva MV, Loures CG, Vieira Alves LC, Cruz de Souza L, Gomes Borges KB, Graças Carvalho M. Alzheimer's disease: risk factors and potentially protective measures. J Biomed Sci. 2019; 26(33):1-11. [DOI:10.1186/s12929-019-0524-y] [PMID] []

8. Perkovic MN, Pivac N. Genetic markers of alzheimer's disease.

9. Adv Exp Med Biol. 2019; 1192:27-52.

10. Mintun MA, LO AC, Duggan Evans C, Wessels AM, Ardayfio PA, Andersen SW, Shcherbinin S, et al. Donanemab in early alzheimer's disease. N Engl J Med. 2021; 384:1691-704. [DOI:10.1056/NEJMoa2100708] [PMID]

11. Sahiner M, Yilmaz AS, Gungor B, Sahiner N. A review on photo-therapeutic approaches in alzheimer's disease. J Funct Biomater. 2023; 14:50. [DOI:10.3390/jfb14010050] [PMID] []

12. Asanomi Y, Shigemizu D, Akiyama SH, Miyashita A, Mitsumori R, Har N, et al. A functional variant of sharpin confers increased risk of late onset alzheimer's disease. J Hum Genet. 2022; 67:203-8. [DOI:10.1038/s10038-021-00987-x] [PMID] []

13. Asanomi Y, Shigemizu D, Miyashita A, Mitsumori R, Mori T, Hara N, et al. A rare functional variant of sharpin attenuates the inflammatory response and associates with increased risk of late-onset alzheimer's disease. Mol Med 2019; 25(20):1-9. [DOI:10.1186/s10020-019-0090-5] [PMID] []

14. Moreno-Grau S, de Rojas I, Hernández I, Quintela I, Montreal L, Alegret M, et al. Genome-wide association analysis of dementia and its clinical endophenotypes reveal novel loci associated with alzheimer's disease and three causality networks. Alzheimers Dement. 2019; 15(10):1333-47. [DOI:10.1016/j.jalz.2019.06.4950] [PMID]

15. Park JY, Lee D, Lee JJ, Gim J, Gunasekaran TI, Choi KY, et al. A missense variant in sharpin mediates alzheimer's disease specific brain damages. Transl Psychiatry. 2021; 11:590. [DOI:10.1038/s41398-021-01680-5] [PMID] []

16. Kamboh MI. Genomics and functional genomics of alzheimer's disease. Neurotherapeutics. 2022; 19:152-72. [DOI:10.1007/s13311-021-01152-0] [PMID] []

17. Soheili-Nezhad S, Jahanshad N, Guelfi S, Khosrowabadi R, Saykin AJ, Thompson P.M, et al. Imaging genomics discovery of a new risk variant for alzheimer's disease in the postsynaptic sharpin gene. Hum Brain Mapp. 2020; 41:3737-48. [DOI:10.1002/hbm.25083] [PMID] []

18. Yin J, Feng W, Yuan H, Yuan J, Wu L. Association analysis of polymorphisms in STARD6 and near ECHDC3 in alzheimer's disease patients carrying the apop ε4 allele. Neuropsychiatr Dis Treat. 2019; 15:213-18. [DOI:10.2147/NDT.S186705] [PMID] []

19. Esmaeili Anvar N, Bazazzadegan N, Ohadi M, Kamali K. Association between interleukin 16 gene polymorphisms (rs1131445, rs4072111) and late onset of alzheimer's disease in Iranian patients. Iranian J Age. 2016; 11(1):64-71. [DOI:10.21859/sija-110164]

20. Hampanezhad Y, Khalaj-Kondori M, Khodaei M, Talebi M. Frequency of rs2282649 and rs12285364 polymorphisms in SORL1 gene and their association with alzheimer's disease in Azari population in northwest of Iran. Sci J Kurd Uni Med Sci. 2020; 24:46-56. [Full text in Persian] [DOI:10.29252/sjku.24.6.46]

21. Kim YJ, Paik JW, Kang WS, Kim SK, Lee K. Genetic association of STARD6 polymorphisms with alzheimer's disease in a Korean population. J Neurol Sci. 2016; 366:100-1. [DOI:10.1016/j.jns.2016.05.013] [PMID]

22. Bossù P, Ciaramella A, Moro ML, Bellincampi L, Bernardini S, Federici G, et al. Interleukin-18 gene polymorphisms predict risk and outcome of alzheimer's disease. J Neurol Neurosurg Psychiatry. 2007; 78(8):807-11. [DOI:10.1136/jnnp.2006.103242] [PMID] []

23. Cordeiro Q, Noguti R, Bottino C, Vallad H. Study of association between genetic polymorphisms of phospholipase A2 enzymes and alzheimer's disease. Arq Neuropsiquiatr. 2010; 68(2):189-93. [DOI:10.1590/S0004-282X2010000200007] [PMID]

24. Desikan RS, Schork AJ, Wang Y, Thompson WK, Dehghan A, Ridker PM, et al. Polygenic overlap between C-reactive protein, plasma lipids, and alzheimer disease. Circulation. 2015; 131:2061-69. [DOI:10.1161/CIRCULATIONAHA.115.015489] [PMID] []

25. Andrade-Guerrero J, Santiago-Balmaseda A, Jeronimo-Aguilar P, Vargas-Rodríguez I, Cadena-Suárez AR, Sánchez-Garibay C, et al. Alzheimer's disease: An updated overview of Its genetics. Int J Mol Sci. 2023; 24(4):3754. [DOI:10.3390/ijms24043754] [PMID] []